The Reserve Bank of New Zealand (RBNZ) cut the official cash rate (OCR) by 25 bp to 2.25%, in line with expectations, likely marking the final step in the easing cycle that began in 2024.
The decision was made in an environment where CPI inflation stands at 3%, the upper end of the 1–3% target band. Forecasts project a decline toward 2% by mid-2026. New Zealand’s economy contracted by 0.9% in Q2. However, the RBNZ believes the decline was driven by temporary factors and seasonal distortions. The latest projections suggest a moderate rebound. The committee voted 5 to 1 in favor of a 25 bp cut while stressing that future decisions will depend on inflation dynamics and economic activity.
During the press conference, acting Governor Christian Hawkesby described the decision as the beginning of a return to a more “boring” monetary-policy environment. Hawkesby hopes that by 2026 the RBNZ will disappear from front-page headlines, inflation will move closer to 2%, and economic growth will normalize. He emphasized that risks to the forecasts are balanced: global inflation and political uncertainty remain challenges, but domestic inflation expectations are becoming more firmly anchored and the labor market shows signs of stabilizing. As he stated, every option remains “on the table,” but the central projection assumes no further cuts.
Markets interpreted the combination of a dovish move and balanced rhetoric as less dovish than expected, triggering a sharp strengthening of the New Zealand dollar. Following the announcement and press conference, the NZD strengthened by about 1.10% against the U.S. dollar, becoming the strongest currency in the G10 basket. The move reflects investors’ belief that the easing cycle is nearing its end and that the RBNZ is signaling macroeconomic comfort.
Daily summary: Nervous anticipation, SaaS sell-off and weak macro data
“SaaS-pocalypse” continued
Three Markets to Watch in the Week Ahead (10.04.2026)
US OPEN: The market calms down ahead of earnings season
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
